- Academic and Private Partnership to Improve Informed Consent Forms Using a Data Driven Approach
- Reasons and Reproduction: Gene Editing and Genetic Selection
- Response to Open Peer Commentaries on “Do Clinicians Have a Duty to Participate in Pragmatic Clinical Trials?”
- When Anti-Discrimination Discriminates
- Digital Simulacra, Bias, and Self-Reinforcing Exclusion Cycles
- Health Digital Twins, Legal Liability, and Medical Practice
- Should We be More Worried about Digital Simulacra in Healthcare Being Our “Caricatures,” Rather than Our “Replicas”?
- What Does True Equality in Assisted Dying Require?
- Value of and Value in Language: Ethics and Semantics in Physician-Assisted Suicide Laws
- MAID in America: Expanding Our Gaze on the Ethics of Assistance
- Acknowledging Complexity and Reimagining IRBs: A Reply to Discussions of the Protection–Inclusion Dilemma
- Current Medical Aid-in-Dying Laws Discriminate against Individuals with Disabilities
- Integrating Social Determinants of Health into Ethical Digital Simulations
- Digital Simulacra and the Call for Epistemic Responsibility: An Ubuntu Perspective
- Aid in Dying Unaided?
- Epistemic Value of Digital Simulacra for Patients
- Permit Assisted Self-Administration: A Response to Open Peer Commentaries on Neurologic Diseases and Medical Aid in Dying: Aid-in-Dying Laws Create an Underclass of Patients Based on Disability
- Accommodating Aid-in-Dying Safeguards for Patients with Neurologic Disease
- Care Depersonalized: The Risk of Infocratic “Personalised” Care and a Posthuman Dystopia
- Beyond Words: Reconsidering the Moral Distinction of Action in Consent for Assisted Dying
- Enabling the Nonhypothesis-Driven Approach: On Data Minimalization, Bias, and the Integration of Data Science in Medical Research and Practice
- Distinguishing “Reasonable Accommodation” From Physical Assistance in Aid-in-Dying
- Digital Simulacra: Circumventing Diversity and Inclusion
- Preventing the Slide down the Slippery Slope from Assisted Suicide to Euthanasia While Protecting the Rights of People with Disabilities Who Are “Not Dead Yet.”
- The Importance of Self-Administration of Aid-in-Dying Medication
- Can People Work Together to Create a Self-Administered Act? No. Should They Work Together to Repeal the End of Life Option Act? Yes
- In Their Own Image: Ethical Implications of the Rise of Digital Twins/Clones/Simulacra in Healthcare
- AI-Based Medical Solutions Can Threaten Physicians’ Ethical Obligations Only If Allowed to Do So
- Individuals and (Synthetic) Data Points: Using Value-Sensitive Design to Foster Ethical Deliberations on Epistemic Transitions
- Ethics, First
- Digital Simulacra Mark an Ontological Shift in Biomedicine with Far-Reaching Consequences for Real Patients
- Proposed Principles for International Bioethics Conferencing: Anti-Discriminatory, Global, and Inclusive
- When Treatment Pressures Become Coercive: A Context-Sensitive Model of Informal Coercion in Mental Healthcare
- Ethics Education for Healthcare Professionals in the Era of chatGPT and Other Large Language Models: Do We Still Need It?
- AUTOGEN: A Personalized Large Language Model for Academic Enhancement—Ethics and Proof of Principle
- Pragmatic Research and Quality Assessment/Improvement Initiatives: Kindred Spirits
- Some Treatments Over Objection, Not Others, Are Ethically Justifiable When Managing Anorexia Nervosa
- Challenges in the Ethics and Implementation of Learning Health Care Systems
- Ethical Pragmatic Clinical Trials Require the Virtue of Cultivated Uneasiness
- “A Community-Engaged Approach to Address Collateral Findings in Embedded Research”
- Ethically Alluring but Legally Destructive
- Tube Feed or Not Tube Feed: Ethics beyond the Consult Question
- Reasons for Not Participating in PCTs: The Comparative Case of Emergency Research under an Exception from Informed Consent (EFIC)
- Blurred Boundaries: Toward an Expanded Ethics of Research and Clinical Care
- Response to Open Peer Commentaries on “Think Pragmatically: Investigators’ Obligations to Patient-Subjects When Research is Embedded into Care”
- A Paradigm of Investigator Duty to Multiple Stakeholder Participants
- Special Considerations When Research is Embedded within Community Health Centers
- Medicine’s Commitment to Science and the Duties That Bind Clinicians
- Canceling Tuskegee
- “I Don’t Want to Gain Weight!” The Ethics of Tube Feeding Over the Objection of a Patient with Anorexia Nervosa
- Should the Incapacitated Patient’s Prior Refusal of Dialysis Be Honored? The Value of a Systematic Approach to Gathering Data in an Ethics Consultation
- Patient Ineligibility as a Barrier to Participation in Clinical Trials
- Clinicians’ Duty to Participate in Pragmatic Clinical Trials: Further Considerations
- A Neuroethical Analysis of Pragmatic Clinical Trials: Balancing Diverse Interests associated with Collateral Findings
- Treatment over Objection (in Anorexia Nervosa): Capacity Is Not the Whole Story
- More-Than-Partial Entrustment in Pragmatic Clinical Trials
- Why Clinicians Do Not Have a Duty to Participate in Pragmatic Clinical Trials
- Distinguishing Clinical and Research Risks in Pragmatic Clinical Trials: The Need for Further Stakeholder Engagement
- End-to-End Integration of Pragmatic Trials Into Health Care Settings
- Is There a Doctor in the House?
- Pragmatic Research and Clinical Duties: Solutions Through Precision AI-Enabled Clinically Embedded Research
- Refusal of Dialysis: Context Matters
- Participation in Pragmatic Clinical Trials: A Matter of Physicians’ Professional Ethics?
- Dialysis Refusal: Discerning the Credibility of a Prior Verbal Directive
- Seizing the Opportunity to Improve Ethical Oversight of Clinical Research
- Progressing from “Whether to” to “How to” Conduct Pragmatic Trials
- Not Wanting Dialysis Does Not Necessarily Mean Non-Acceptance—Words Matter
- What Should ChatGPT Mean for Bioethics?
- Beyond Suppressing Testosterone: A Categorical System to Achieve a “Level Playing Field” in Sport
- A Public Health Ethics Framework for Populations with Limited English Proficiency
- Oppressive Medical Objects and Spaces: Response to Commentaries
- Affect, Values and Problems Assessing Decision-Making Capacity
- Moral Stress and Moral Distress: Confronting Challenges in Healthcare Systems under Pressure
- Critiquing the Critique of Advocacy
- Getting It Right: How Public Engagement Might (and Might Not) Help Us Determine What Is Equitable in Genomics and Precision Medicine
- Rethinking the “Public” and Rethinking “Engagement”
- Hypervisibility, Surveillance, and Bounded Justice through Data-Driven Health Equity Efforts
- What Constitutes Ethical Engagement with Africa and the Global South?
- Tackling Structural Injustices: On the Entanglement of Visibility and Justice in Emerging Technologies
- The Dialectics of Racial Invisibility and Hyper-Visibility under the Mestizaje Discourse in Latin America
- Ethical, Legal, and Social Implications of Genomics Research: Implications for Building a More Racially Diverse Bioethics Workforce
- Curiosity and Uncertainty Resolution: Inflating the Perceived Utility of Genetic Information
- Translational Justice in Human Gene Editing: Bringing End User Engagement and Policy Together
- Who Is Responsible for Promoting Equity in Rare Disease Research?
- Ethical Considerations in Clinical Trials for Rare Genetic Diseases: The Case of Huntington’s Disease
- Deliberative Mini-Publics and Equity: Procedural Benefits and Promising Outcomes for Gene Editing
- The Australian Citizens’ Jury and Global Citizens’ Assembly on Genome Editing
- Innovating for a Just and Equitable Future in Genomic and Precision Medicine Research
- Unbounding ELSI: The Ongoing Work of Centering Equity and Justice
- Whose Genome? Which Genetics?
- Imperfect Methods for Imperfect Democracies: Increasing Public Participation in Gene Editing Debates
- STS and Bioethics: Forging New Synergies for Exploring the Potentials and Pitfalls of Public Engagement with New Biotechnologies
- Reconfiguring Health: The Importance of Recognizing Embodied Subjectivity and Social Dynamics in Health
- Narrative Equity in Genomic Screening at the Population Level
- Social Inequality and Human Genome Editing: A Nuanced Analysis of the Ubuntuan Ethical Prism
- Public Engagement in Shaping Bioethics Policy: Reasons for Skepticism
- Rare Disease, Advocacy, and Caregiver Burnout
- Addressing the Burdens That Newborn Screening Imposes on Underserved Communities
- From Community-Based Carrier Programs to Opportunistic Carrier Screening: How the Objective of Carrier Screening Was Lost in Translation
- Reliance on Advocacy is the Symptom Not the Disease
- When Less is More: Lessons for Expanded Carrier Screening from Newborn Sequencing Research
- What Difference Can Public Engagement in Genome Editing Make, and for Whom?
- Disclosing Reproductive Genetic Carrier Status: What about the Donor?
- Racism and the Textures of Visibility
- The Intrinsic Value of Public Deliberation in the Governance of Human Genome Editing
- The Other Side of the Self-Advocacy Coin: How For-Profit Companies Can Divert the Path to Justice in Rare Disease
- Ethical Responsibilities for Companies That Process Personal Data
- ECMO as a Palliative Bridge to Death
- Withdrawal of ECMO Support over the Objections of a Capacitated Patient can be Appropriate
- Balancing Protection and Inclusion by Including More Non-Scientist and Nonaffiliated Members on IRBs
- Battle of the Bridge: Ethical Considerations Related to Withdrawal of ECMO Support for Pediatric Patients over Family Objections
- Adolescents, Sensitive Topics, and Appropriate Access to Biomedical Prevention Research
- Why Deny ECMO-DT to the Incapacitated?
- The Divergence of Technical and Human Teleology
- Can the Extraordinary Become Ordinary? Re-Examining the Ethics of ECMO-DT
- Bridge or Destination: Ethical Complexity, Emotional Unrest
- “Sorry, but the Ethicist Said Your Life Isn’t Actually Worth Living”: Misunderstanding Ethics and the Role of the Ethics Consultant
- Integrating Community Perspectives on Inclusion and Protection into IRB Structures
- Reflection Requires Representation
- The Research Protection-Inclusion Dilemma in Pregnancy: Who is Being Protected? Who is Being Included?
- Unilateral Withdrawal, Technological Creep, and the Role of Proportionality in ECMO Policy
- ECMO as a Destination Therapy is Not a Bridge to Nowhere
- ECMO: What Would a Deliberative Public Judge?
- Ethical Withdrawal of ECMO Support Over the Objections of Competent Patients
- Ethical Issues in the Transition to ECMO as a Destination Therapy
- When Critically Ill Patients with Decision Making Capacity and No Further Therapeutic Options Request Indefinite Life Support
- The Moral Relevance of ECMO Bridge Maintenance
- A Bridge to Nowhere
- The Human and Humanity that Differentiate Withholding from Withdrawing Life-Sustaining Therapy: An ECMO Bridge to Nowhere
- Personalizing Care and Communication at the Limits of Technology
- Fairly Distributing the Distributive Justice Argument Permits Stopping ECMO
- Significant Protection-Inclusion Tensions in Research on Medical Emergencies: A Practical Challenge for IRBs
- Unilateral ECMO Withdrawal and the Argument From Distributive Justice
- Community Engagement and the Protection-Inclusion Dilemma
- What is Fair Representation in Research?
- Leveraging the Power of the Centralized IRB Review
- When the Bridge Crumbles: Balancing ECMO-DT With Transplant Program Needs
- The ECMO Bridge and 5 Paths
- The Protection-Inclusion Dilemma: A Global Distributive Justice Perspective
- Wither Vulnerability? The Over/Under Protection Dilemma and Research Equity
- IRBs and Industry Sponsors: Clash of Priorities
- Don’t Ask Too Much: Non-maleficence as the Guiding Principle in IRB Decision-Making
- Included but Still Invisible?: Considering the Protection-Inclusion Dilemma in Qualitative Research Findings
- Researching Those in the Shadows: Undocumented Immigrants, Vulnerability, and the Significance of Research
- Bounded Justice, Inclusion, and the Hyper/Invisibility of Race in Precision Medicine
- Revive and Refuse: Capacity, Autonomy, and Refusal of Care After Opioid Overdose
- The Promise and Reality of Public Engagement in the Governance of Human Genome Editing Research
- Promoting Equality in the Governance of Heritable Human Genome Editing through Ubuntu: Reflecting on a South African Public Engagement Study
- Rare Disease, Advocacy and Justice: Intersecting Disparities in Research and Clinical Care
- Is It Just for a Screening Program to Give People All the Information They Want?
- Slowing the Slide Down the Slippery Slope of Medical Assistance in Dying: Mutual Learnings for Canada and the US
- Returning Individual Research Results from Digital Phenotyping in Psychiatry
- Lost in Gestation: On Fetonates, Perinates, and Gestatelings
- On the Permissibility of Elective Ectogestation
- Ethical Aspects of Machine Listening in Healthcare
- Differences in Degree-not-Kind-of Responsibility within Conversational Artificial Intelligence
- Beyond a Medicalized View of Reproduction: Recentering Pregnant People in the Ethics of Ectogenesis
- Capabilities and Stakeholders – Two Ways of Enriching the Ethical Debate on Artificial Womb Technology
- Tools, Agents or Something Different? – The Importance of Techno-Philosophical Premises in Analyzing Health Technology
- Therapists or Replicants? Ethical, Legal, and Social Considerations for Using ChatGPT in Therapy
- A Different Take on the Law and Ethics of AWT
- Beyond the Domains: What Would be the Fundamental Ethical Questions in the Development of the Artificial Womb
- Deception Mode: How Conversational AI Can Respect Patient Autonomy
- Artificial Wombs or Artificial Feminism: What Is Wrong With Being Pregnant?
- Conversational Artificial Intelligence—Patient Alliance Turing Test and the Search for Authenticity
- Toward Relational Diversity for AI in Psychotherapy
- The Postphenomenological Impact of Conversational Artificial Intelligence on Autonomy and Psychological Integrity
- Justice, Vulnerable Populations, and the Use of Conversational AI in Psychotherapy
- Responsible Use of CAI: An Evolving Field
- Conversational Artificial Intelligence and the Potential for Epistemic Injustice
- Artificial Womb on Maternal Request and Without the Father’s Consent: Ethical Perspectives Through a Principlist Approach
- Artificial Womb Technology and the Restructuring of Gestational Boundaries
- Therapeutic Conversational Artificial Intelligence and the Acquisition of Self-understanding
- Therapeutic Artificial Intelligence: Does Agential Status Matter?
- Staying Curious With Conversational AI in Psychotherapy
- Is the Mother’s Decision to Opt for Artificial Womb Technology Always “Supererogatory”?
- Why We Should Understand Conversational AI as a Tool
- Bias and Epistemic Injustice in Conversational AI
- Relational Reciprocity from Conversational Artificial Intelligence in Psychotherapy
- Artificial Womb Technology, Catholic Health Care, and Social Justice
- Thinking Inside the Bag: Patient Selection, Framing the Ethical Discourse, and the Importance of Terminology in Artificial Womb Technology
- The Dilemmas of Artificial Wombs: Conventional Ethics and Science Fiction
- The Actionless Agent: An Account of Human-CAI Relationships
- Feminist Concerns About Artificial Womb Technology
- Viewing CAI as a Tool Within the Mental Health Care System
- Abortion, Artificial Wombs, and the “No Difference” Argument
- Expanding the Frame: An Afrofuturist Response to Artificial Womb Technology
- Is the Algorithm Good in a Bad World, or Has It Learned to be Bad? The Ethical Challenges of “Locked” Versus “Continuously Learning” and “Autonomous” Versus “Assistive” AI Tools in Healthcare
- The Ethical and Legal Status of ‘Fetonates’ Or ‘Gestatelings’
- Toward a Broader Conception of Equity in Artificial Womb Technology
- Tools and/or Agents? Reflections on Sedlakova and Trachsel’s Discussion of Conversational Artificial Intelligence
- No Substitute: The False Promise of Artificial Womb Technology as an Alternative to Abortion
- Artificial Placenta – Imminent Ethical Considerations for Research Trials and Clinical Translation
- Conversational Artificial Intelligence and Distortions of the Psychotherapeutic Frame: Issues of Boundaries, Responsibility, and Industry Interests
- The PHERCC Matrix. An Ethical Framework for Planning, Governing, and Evaluating Risk and Crisis Communication in the Context of Public Health Emergencies
- What is Death and Why Do We Insist on the Dead Donor Rule? A Response to Our Critics
- Capacities to Refuse Treatment: A Reply
- The Bioethics of Environmental Injustice: Ethical, Legal, and Clinical Implications of Unhealthy Environments
- Rationing, Responsibility, and Vaccination during COVID-19: A Conceptual Map
- Prenatal Testing: Responsibility and Reality
- Moral Distress as Critique: Going beyond ‘Illegitimate Institutional Constraints’
- Moral Distress and Justifiable Constraints on Moral Agency
- Measuring Moral Distress: Improving the Tools by Educating Clinicians
- Preventing Bias in Medical Devices: Identifying Morally Significant Differences
- Moral Distress in Military Medicine: Toward Analysis of, and Approach to Measurement, Prevention and Care
- Moral Distress: The Context of Measurement
- Medicalized Oppression: Labels of “Violence Risk” in the Electronic Medical Record
- Measuring Moral Distress and its Various Sources
- Historicizing Technological Hegemony
- Moral Distress Tools: Not Just a Question of What but Why Are We Measuring?
- Measure for Measure: Condemning the Actor and Not the Fault
- On Racist Tools and the Bioethics Lexicon
- How Materialized Oppression Contributes to Bioethics
- How Medical Technologies Materialize Oppression
- Instruments of Moral Distress: An Analysis Based on Scientificity and Application Value
- Systems, Wrongs, and Moral Aggregation
- Materialized Oppression in Inpatient Psychiatric Unit Design
- Ethics Debriefs and Moral Distress: What are we Doing?
- Evolving Measures of Moral Distress: Imperfect Does Not Mean Irrelevant
- Moral Distress Is a Systemic Problem Requiring Organizational Solutions
- Racism-Conscious Praxis: A Framework to Materialize Anti-Oppression in Medicine, Public Health, and Health Policy
- Capturing Moral Distress as a Global Phenomenon in Healthcare
- Prenatal Testing for Non-Medical Traits
- Bioethicists Are Not so Divided on Reproductive Testing for Non-Medical Traits: Emerging Perspectives on Polygenic Scores
- Including Non-Medical Traits in the NIPT: What Can We Learn from an Ethics of Care Approach?
- Role of Vulnerability and Control in Prenatal Testing Ethical Decision-Making
- Genomic Uncertainty as a Burden for Reproductive Choice? The Problem of Probabilistic Causation in Non-Invasive Prenatal Testing
- Security and Sharing of NIPT Data Are the Basis of Ethical Decision-Making Related to Non-Medical Traits
- Nurtured Genetics: Prenatal Testing and the Anchoring of Genetic Expectancies
- Anticipatory Governance of Noninvasive Prenatal Testing for “Non-Medical” Traits: Lessons from Regulation of Medically Assisted Reproduction
- The Slippery Slope of Prenatal Testing for Social Traits
- The Need for Diverse Empirical Data to Inform the Use of Polygenic Risk Scores in Prenatal Screening
- Expanding Our Thoughts about Autonomy in Relation to Whether We Should Offer Genetic Testing for Nonmedical Traits
- Considering the Collective in Ethical Decision-Making Concerning Non-Medical Uses of Noninvasive Prenatal Testing
- Terminology and Consistency
- Consistency of What? Appropriately Contextualizing Ethical Analysis of Non-Invasive Prenatal Testing
- Going Back to Basics: What is the Target of Prenatal Screening?
- Noninvasive Testing for “Non-Medical” Traits: A Misplaced Expressive Concern, Tough Policy Choices
- The Potential Role of Nudging in Expanded Noninvasive Prenatal Testing
- Precision Medicine for Whom? Public Health Outputs from “Genomics England” and “All of Us” to Make Up for Upstream and Downstream Exclusion
- ChatGPT: Temptations of Progress
- Response to Open Peer Commentaries on “Ethical Issues in Using Behavior Contracts to Manage the ‘Difficult’ Patient Family”
- Clarifying the DDR and DCD
- DCD Donors Are Dying, but Not Dead
- Never Let Me Go: “Almost Dead” Isn’t Good Enough
- The Dead Donor Rule, Reversibility and Donor Wishes
- Is Transparency about the Line between Life and Death Good for Organ Donation?
- Why We Still Need a Substantive Determination of Death
- The Needs to Focus on Process and Precise Language in Ethical Determination of cDCD
- Not Dead, but Close Enough? You Cannot Have Your Cake and Eat It Too in Satisfying the DDR in cDCD
- Some Problems with the ‘It Has Been Decided That You Will Die and Are No Longer in Need of Your Organs Donor Rule’
- Changing the Focus in the Donation After Circulatory Death Debates
- Dead Enough? NRP-cDCD and Remaining Questions for the Ethics of DCD Protocols
- Donor Rules—Dead and Living
- Donors and Organs at the Borders of Vitality and Public Trust: Why DCD Donors Must Be Dead and Not Dying
- The Dead Donor Rule Is Not Morally Sufficient
- Don’t Leave the Heart Behind
- Almagest Again? An Epistemological Critique of Nielsen Busch and Mjaaland
- Defining the Cause of Death and Vitality of Organs in the Ethical Analysis of Controlled Donation after Circulatory Death Procedures
- Pragmatic Aspects of Controlled Donation after Circulatory Death and Ethical Considerations for Alternative Approaches
- Protecting Life and Ensuring Death—Confounding the Dead Donor Rule
- The Dead Donor Rule Does Require that the Donor is Dead
- Cerebral Circulatory Arrest and the Dead Donor Rule
- Death Lost in Translation
- Normothermic Regional Perfusion, Causes, and the Dead Donor Rule
- The End of Personhood
- An Overview of Ethical Issues Raised by Medicolegal Challenges to Death by Neurologic Criteria in the United Kingdom and a Comparison to Management of These Challenges in the USA
- Spheres of Morality: The Ethical Codes of the Medical Profession
- Beyond Mediation: A Toolkit Approach to Preventing and Managing Conflict with Patients and Families in Difficulty
- The Fallibility of Personal Experience
- Assisted Dying: More Attention Should Be Paid to the Epistemic Asset of Personal Experience
- The Problem of “Relevant Experience”
- The Patient as Responsible Agent: Ethical Constructs Important to considering Behavioral Contracts for “Difficult” Patients and Families
- Potential Legal Problems Embedded in Behavior Contracts
- Unique Ethical and Practical Considerations in the Use of Behavior Contracts for Families of Minors and Minoritized Populations in Pediatric Settings
- Behavior Contracts and Lessons from Parenting “Rotten” Kids
- The Benefits of Experience Greatly Exceed the Liabilities
- Responding to Parental Objections Over Testing for Death by Neurologic Criteria
- Pediatric Brain Death Testing Over Parental Objections: Not an Ethically Preferable Option
- Behavior Contracts Are Not Psychologically Naïve
- What is “Personal” About Personal Experience? A Call to Reflexivity for All
- “What Does a Life Worth Living Mean to You?” Narrative Approaches to Ethics Consultation in the Context of Trauma, Treatment Refractory Depression, and Life-Sustaining Care Refusals
- Rethinking the Moral Authority of Experience: Critical Insights and Reflections from Black Women Scholars
- Ethics, Engagement, and Escalating Interventions
- Disputes over Diagnosing Death: Is It Ethical to Test for Death by Neurologic Criteria over Parental Objection?
- Trauma-Informed Ethics Consultation in the ICU: Exploring Best Practices in a Case Involving a Self-Inflicted Gunshot Wound
- The Right Tool for the Job: A Taxonomy for Stakeholder Engagement
- Who’s Experience, Which Liability?
- Disability Bioethics and the “Liabilities” of Personal Experience
- Paperwork: Put Behavior Contracts at the Bottom of the Pile
- Bioethics and the Power Asymmetry Contextualizing Experience
- Conflict Over Death by Neurologic Criteria: Caution, Consent, and Nursing Considerations
- Trusting the Ethics Consultant: Adopting a Trauma-Informed Approach to Ethics Consultation
- Transforming Behavior Contracts Into Collaborative Commitments With Families
- Whose Trauma? Who’s Trauma Informed?
- Epistemic Rights and Responsibilities of Digital Simulacra for Biomedicine
- Public Engagement through Inclusive Deliberation: The Human Genome International Commission and Citizens’ Juries
- Do Clinicians Have a Duty to Participate in Pragmatic Clinical Trials?
- Philosophizing Still: A Brief Reintroduction to Clinical Philosophy
- Paired Publication: A Way to Lower One Barrier between Philosophical Insight and Bioethics
- The Mutual Benefit of the Integration of Philosophy and Bioethics – Our Experience from an Interdisciplinary Research Project on (Epi-)Genome Editing
- Bioethics Consultation and First-Order Moral Reasoning: Leaving Philosophy at the Hospital Doors
- A Future for Bioethics?
- Ethics Consultation—A Blind Spot of Philosophy in Bioethics?
- The Place of Philosophy in Bioethics Today? Ancestry Counts
- A Rejection of “Applied Ethics”: Philosophy’s Real Contributions to Bioethics Found Elsewhere
- The Role of Philosophers in Bioethics
- Bioethicist Position Available: Philosophers Need Not Apply
- Bioethics is Philosophy
- Some Reflections on the Importance of Philosophy to Bioethics
- How Philosophy of Science Can Unlock New Methods in Bioethics
- The Place of Bioethics in Philosophy: Toward a Mutually Constructive Integration
- The Disconnection That Wasn’t: Philosophy in Modern Bioethics from a Quantitative Perspective
- Bioethics, Philosophy, and Philosophy of Disability
- Exploring the “Other” Role of Philosophy in Bioethics: The Case of Addressing Moral Distress and Rediscovering Meaning and Purpose
- Rethinking the Role of Experimental Philosophy in Bioethics
- The Role of Philosophy After the Empirical Turn in Bioethics
- Postponed Withholding: Harmful for the Infant and Increasing the Complexity of Decision-Making
- Use Certified Patient Decision Aids to Facilitate Shared Decision Making at the Margins of Viability
- Against Multiplying Clinical Ethics Standards without Necessity: The Case for Parsimony in Evaluating Decision-making Capacity
- Reformulating Decision-making Capacity
- Respecting Patients’ Authority to Make Healthcare Decisions
- OrganEx: What Will It Mean?
- Sharing Decisions When Withdrawing a Technology Is Not the Same as Withholding It
- Postponed Withholding: The Wrong Nudge
- Informed Nondissent at the Limits of Viability
- Deferring Decision-making in the Face of Uncertainty
- Postponed Withholding Does Not Postpone Attachment
- What Is the Ethical Goal of Empowering Parents in Emergent Decision-making about Their Premature Newborn?
- Supported Decision Making, Treatment Refusal, and Decisional Capacity
- The Postponed Withholding Model: An Autoethnographic Analysis
- Should We Aspire to Be Rational About Letting Babies Die?
- The Birth of Tragedy? Extremely Premature Births and Shared Decision-Making
- Embrace the Gray: How Tackling the Clinical Complexities of the Gray Zone Will Improve Decision-making
- Goals- and Burdens-based DMC as Expressions of Value Rather than Manifestations of DMC
- Authority, Autonomy, and Capacity
- Why Not Jump out of Decision-Making Capacity?
- The Path More Easily Reversed: Postponed Withholding at Borderline Viability
- Delayed Withholding: Disguising Withdrawal of Life Sustaining Interventions in Extremely Preterm Infants
- Postponed Withholding: An Ethical Tool for Health Care Personnel to Empower Parents
- Optimizing Decision-Making in the Gray Zone at Birth
- Default Withdrawal: Exacerbating Mistrust for Our Most Vulnerable Families
- E-Cigarettes, the FDA, Public Health, and Harm Reduction: A Response to the Open Peer Commentaries
- An AI Bill of Rights: Implications for Health Care AI and Machine Learning—A Bioethics Lens
- Report Card Time: How Has the Biden Administration Addressed the U.S. Hispanic Community’s Social Determinants of Health?
- Bioethics and the Moral Authority of Experience
- Clinical Ethics – To Compute, or Not to Compute?
- Response to Open Peer Commentaries on “Privacy and Health Practices in the Digital Age”
- Against Over-Protectionism: Riskier Decisions Require Clearer Evidence of Capacity But Don’t Call for Stricter Criteria
- E-Cigarette Use and Regulation: A Comparative Analysis between the United States, the UK, and China
- Conceptual Compatibility and Transparency in Capacity Assessments
- Stepping Up or Stepping Back: FDA Roles in Producing and Shaping Knowledge of Pediatric Covid-19 Vaccines
- When Limiting Liberty, Tread Carefully: Autonomous Free Choices Should Not Be Overruled Because of the Beliefs and Values of the Decider
- Advice on Vaping in the Face of Empirical and Ethical Uncertainty
- When to Disclose a Borderline Incidental Finding
- Against Whitecoat Washing: The Need for Formal Human Rights Assessment in International Collaborations
- Respecting Autonomy and Balancing Benefits by Disclosing the Secondary Finding of Klinefelter’s
- Clarifying the Blurry Boundaries between Research and Clinical Care
- The Importance of Defining Actionability as Related to Disclosure of Secondary Findings Identified in Research
- An Externalist, Process-Based Approach to Supported Decision-Making
- Limitations on the Capability of the FDA to Advise
- We Don’t Offer What Can’t Be Chosen: Why Harmful Consequences Should Not Be “Decisive” in Assessing Decision-Making
- To Disclose or Not to Disclose: Secondary Findings of XXY Chromosomes
- The Nature of Harm: A Wine-Dark Sea
- The Value of Value in Decision-Making Competence Assessments
- Determinations of Competence Ought Not to Be Primarily Grounded in Paternalistic Justifications regarding Welfare
- “Harmful” Choices and Subjectivity: Against an Externalist Approach to Capacity Assessments
- Against Externalism: Maintaining Patient Autonomy and the Right to Refuse Medical Treatment
- Against Externalism in Capacity Assessment—Why Apparently Harmful Treatment Refusals Should Not Be Decisive for Finding Patients Incompetent
- Preserve Patient Autonomy; Resist Expanding the Harm Principle to Override Decisions by Competent Patients
- On the Relationship between Competence and Welfare
- E-Cigarettes, the FDA’s Strategic Orientation, and Lessons from the Opioid Crisis
- Moral Wrongs, Epistemic Wrongs, and the FDA
- Harm Reduction Ethics, Public Health, and the Manufacture of Doubt
- External Dynamics Contextualizing the FDA’s Role in E-Cigarette Regulation